These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10708313)

  • 1. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases.
    Hsieh BT; Hsieh JF; Tsai SC; Lin WY; Wang SJ; Ting G
    Nucl Med Biol; 1999 Nov; 26(8):973-6. PubMed ID: 10708313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.
    Lin WY; Lin CP; Yeh SJ; Hsieh BT; Tsai ZT; Ting G; Yen TC; Wang SJ; Knapp FF; Stabin MG
    Eur J Nucl Med; 1997 Jun; 24(6):590-5. PubMed ID: 9169563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W; Kampen WU; Kampen AM; Henze E
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
    J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
    J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals.
    Ogawa K; Mukai T; Arano Y; Ono M; Hanaoka H; Ishino S; Hashimoto K; Nishimura H; Saji H
    Bioconjug Chem; 2005; 16(4):751-7. PubMed ID: 16029015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.
    Buffa FM; Flux GD; Guy MJ; O'Sullivan JM; McCready VR; Chittenden SJ; Dearnaley DP
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1114-24. PubMed ID: 12761596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Liepe K; Kropp J; Hliscs R; Franke WG
    Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose estimates of 186Re-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: an animal model study.
    van Aswegen A; Roodt A; Marais J; Botha JM; Naudé H; Lötter MG; Goedhals L; Doman MJ; Otto AC
    Nucl Med Commun; 1997 Jun; 18(6):582-8. PubMed ID: 9259533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
    Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL
    Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
    Küçük NO; Ibiş E; Aras G; Baltaci S; Ozalp G; Bedük Y; Canakci N; Soylu A
    Ann Nucl Med; 2000 Aug; 14(4):239-45. PubMed ID: 11023023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.
    Ogawa K; Mukai T; Asano D; Kawashima H; Kinuya S; Shiba K; Hashimoto K; Mori H; Saji H
    J Nucl Med; 2007 Jan; 48(1):122-7. PubMed ID: 17204708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
    ter Heine R; Lange R; Breukels OB; Bloemendal HJ; Rummenie RG; Wakker AM; de Graaf H; Beekman FJ; van der Westerlaken MM; Malingré MM; Wielders JP; van den Berg L; Hendrikse NH; de Klerk JM
    Int J Pharm; 2014 Apr; 465(1-2):317-24. PubMed ID: 24560635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)].
    Holle LH; Humke U; Trampert L; Ziegler M; Kirsch CM; Oberhausen E
    Urologe A; 1997 Nov; 36(6):540-7. PubMed ID: 9487590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of radiopharmaceuticals for diagnosis and therapy of metastatic bone cancer].
    Ogawa K
    Yakugaku Zasshi; 2012; 132(10):1151-7. PubMed ID: 23037700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R; Séra T; Pajor L; Thurzó L; Láng J; Csernay L; Pávics L
    Orv Hetil; 2000 May; 141(19):1019-23. PubMed ID: 10846424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer.
    Graham MC; Scher HI; Liu GB; Yeh SD; Curley T; Daghighian F; Goldsmith SJ; Larson SM
    Clin Cancer Res; 1999 Jun; 5(6):1307-18. PubMed ID: 10389913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes.
    Lin WY; Hsieh JF; Lin CP; Hsieh BT; Ting G; Wang SJ; Knapp FF
    Nucl Med Biol; 1999 May; 26(4):455-9. PubMed ID: 10382850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhenium-188 HEDP to treat painful bone metastases.
    Li S; Liu J; Zhang H; Tian M; Wang J; Zheng X
    Clin Nucl Med; 2001 Nov; 26(11):919-22. PubMed ID: 11595844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.